Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
Yuankai Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingwen Wang(Beijing Tongren Hospital), Xiaoqiong Tang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Qingshu Zeng(Anhui Medical University), Lugui Qiu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianqiu Wu(Jiangsu Cancer Hospital), Jianfeng Zhou(Tongji Hospital), Qifa Liu(University of Science and Technology of China), Yuqin Song(Peking University), Hongming He(Fujian Provincial Cancer Hospital), Weili Zhao(Shanghai Jiao Tong University), Haiyan Yang(Zhejiang Cancer Hospital), Mei Dong(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiequn Chen(Northwestern Polytechnical University), Jianmin Yang(Canadian Food Inspection Agency), Yi Luo(Zhejiang Lab), Xiuhua Sun(Dalian Medical University), Hang Su(307th Hospital of Chinese People’s Liberation Army), Jingyan Xu(Nanjing Drum Tower Hospital), Jianzhen Shen(Fujian Medical University), Ming Hou(Qilu Hospital of Shandong University), Xin Wang(Shandong Provincial Hospital), Peng Liu(Sun Yat-sen University), Xiaoling Li(Southwest University), Xiaodong Wang(Xidian University), Wenyu Li(Shenyang Agricultural University), Ting Liu(Chinese PLA General Hospital), Lihong Liu(Hebei Medical University), Zhihui Zhang(Army Medical University), Zhen Cai(First Affiliated Hospital Zhejiang University), Huo Tan(First Affiliated Hospital of Guangzhou Medical University), Wei Xu(Zhejiang International Studies University), Huaqing Wang(Beijing University of Technology), Jie Jin(First Affiliated Hospital Zhejiang University), Lin Liu(Dankook University), Bo Jia(Inner Mongolia Medical University), Jian‐Min Luo(Hebei Medical University), Huiqiang Huang(Sun Yat-sen University), Zhiming Li(Sun Yat-sen University), Pingyong Yi(Hunan Cancer Hospital), Xiaobing Huang(Sichuan Provincial Hospital of Traditional Chinese Medicine), Liping Su, Yuhuan Gao(Hebei Medical University), Rong Liang(Xijing Hospital), Zimin Sun(Anhui Provincial Hospital), Zhengming Jin(Soochow University), Jinghua Wang(Beijing Tongren Hospital), Kaiyang Ding(Anhui Provincial Hospital), Xi Zhang(Army Medical University), Huilai Zhang(Shanxi Medical University)
Cited by 256
Related Papers
Targeting the Wnt/β-catenin signaling pathway in cancer
|Journal of Hematology & Oncology|2020|1.4k
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
|The Lancet Oncology|2016|1.2k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
|Molecular Cancer|2020|578
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments
|Molecular Cancer|2021|476